Please remember that these discussion boards are a public forum, which means open to the public (i.e. non-CSN members) and the content can be found via internet search engines.
Members are strongly advised not to share personal identifiers such as real names, email address, telephone number, street address, etc. This information can be used to identify you and link you to the content you provide.
Other areas of CSN are restricted to members only and cannot be found by search engines.
Prostate Cancer
Archives for December 2017
Discussion List
Newly diagnosed - is CK for us?
My husband was diagnosed with PC in July. PSA: April 10.4, July 14.7. BX: Gleason's 7 (3+4) in one of 4 cores 30% of total tissue, 7.1MM. I hope this is enough info. Scheduled surgery for January but then learned about CK. Was not told about that option by oncologist. He is a "young age 60" according to doctors so that's…
IMRT recurrent w psa rising, false negative scans but the MRI
Hey, I am under investigation for radioi recurrent pc after IMRT. The latest MRI results came in and I think I have to do the MRI fusion type biopsy. thanks. -k PSA - 11/16/10 to 09/20/13 8.2 to 0.2 (2012 Focused IMRT 75g) 09/20/13 to 10/05/16 0.2 to 2.8 10/05/16 to 10/27/17 2.8 to 5.7 (Now 66) 65 year old man with is a…
Faces of RP
https://www.medicalnewstoday.com/opinions/44196
Prostate cancer in peritoneum with no other metastasis
Hi, My close friend friend was diagnosed with prostate cancer about 18 months ago. Gleason 8. He had surgery and radiation and test results since then were good, until 3 weeks ago when abdominal discomfort led to the discovery of substantial growths in the peritoneum. Biopsy indicates that it is the prostate cancer. So…
casodex
I haven't been on this forum while because perhaps my prostate cancer was the least of my worries. And the fact that taking 50 mg of bicalutamide per day for a few months on and off has kept my PSA down. however, it looks as though the bicalutamide is not working so well as befor. This is usually the case with this…